These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 32463461

  • 21. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway.
    Zhao W, Sun Q, Yu Z, Mao S, Jin Y, Li J, Jiang Z, Zhang Y, Chen M, Chen P, Chen D, Xu H, Ding S, Yu Z.
    Gene; 2018 Sep 05; 670():31-37. PubMed ID: 29803922
    [Abstract] [Full Text] [Related]

  • 22. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
    Zhou YL, Xu YJ, Qiao CW.
    Int J Clin Exp Pathol; 2015 Sep 05; 8(6):6312-22. PubMed ID: 26261507
    [Abstract] [Full Text] [Related]

  • 23. miR-140-3p inhibits progression of non-small cell lung cancer by targeting Janus kinase 1.
    Hu C, Zou Y, Jing LL.
    J Biosci; 2020 Sep 05; 45():. PubMed ID: 32345774
    [Abstract] [Full Text] [Related]

  • 24. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
    Zhang K, Zhang M, Jiang H, Liu F, Liu H, Li Y.
    Biomed Pharmacother; 2018 Sep 05; 105():545-552. PubMed ID: 29886375
    [Abstract] [Full Text] [Related]

  • 25. Long Noncoding RNA SNHG6 Promotes Proliferation and Inhibits Apoptosis in Non-small Cell Lung Cancer Cells by Regulating miR-490-3p/RSF1 Axis.
    Dong Z, Liu H, Zhao G.
    Cancer Biother Radiopharm; 2020 Jun 05; 35(5):351-361. PubMed ID: 32202941
    [Abstract] [Full Text] [Related]

  • 26. Maimendong and Qianjinweijing Tang (Jin formula) suppresses lung cancer by regulation of miR-149-3p.
    Jiang Z, Ma Y, Tian T, Sun Y, Chen H, Lu Y, Wu Y, Jiang H, Li W, Li L, Zhou H, Wu M.
    J Ethnopharmacol; 2020 Aug 10; 258():112836. PubMed ID: 32344160
    [Abstract] [Full Text] [Related]

  • 27. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis.
    Zeng ZL, Zhu HK, He LF, Xu X, Xie A, Zheng EK, Ni JJ, Liu JT, Zhao GF.
    Eur Rev Med Pharmacol Sci; 2020 Mar 10; 24(5):2525-2538. PubMed ID: 32196603
    [Abstract] [Full Text] [Related]

  • 28. MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4.
    Feng H, Ge F, Du L, Zhang Z, Liu D.
    J Cell Mol Med; 2019 Aug 10; 23(8):5282-5291. PubMed ID: 31199581
    [Abstract] [Full Text] [Related]

  • 29. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH, Wu G, Cai Q, Gao XC, Tong F, Zhou R, Zhang RG, Dong JH, Hu Y, Dong XR.
    J Hematol Oncol; 2017 Jun 19; 10(1):125. PubMed ID: 28629431
    [Abstract] [Full Text] [Related]

  • 30. MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1.
    Liu R, Zhang YS, Zhang S, Cheng ZM, Yu JL, Zhou S, Song J.
    Eur Rev Med Pharmacol Sci; 2019 Jan 19; 23(2):679-689. PubMed ID: 30720175
    [Abstract] [Full Text] [Related]

  • 31. Chinese herbal medicine Xiaoji decoction inhibited growth of lung cancer cells through AMPKα-mediated inhibition of Sp1 and DNA methyltransferase 1.
    Zhao S, Wu J, Tang Q, Zheng F, Yang L, Chen Y, Li L, Hann SS.
    J Ethnopharmacol; 2016 Apr 02; 181():172-81. PubMed ID: 26850724
    [Abstract] [Full Text] [Related]

  • 32. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
    Qi G, Li L.
    Biomed Pharmacother; 2020 Jun 02; 126():110100. PubMed ID: 32197208
    [Abstract] [Full Text] [Related]

  • 33. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y, Zhang F, Zhu C, Geng L, Tian T, Liu H.
    Oncotarget; 2017 Mar 14; 8(11):17785-17794. PubMed ID: 28147312
    [Abstract] [Full Text] [Related]

  • 34. MiR-323-3p Targeting Transmembrane Protein with EGF-Like and 2 Follistatin Domain (TMEFF2) Inhibits Human Lung Cancer A549 Cell Apoptosis by Regulation of AKT and ERK Signaling Pathways.
    Fan JM, Zheng ZR, Zeng YM, Chen XY.
    Med Sci Monit; 2020 Feb 03; 26():e919454. PubMed ID: 32009129
    [Abstract] [Full Text] [Related]

  • 35. MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6.
    Sun C, Li S, Yang C, Xi Y, Wang L, Zhang F, Li D.
    Biochem Biophys Res Commun; 2016 Feb 26; 471(1):82-8. PubMed ID: 26845350
    [Abstract] [Full Text] [Related]

  • 36. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
    Xiao P, Liu WL.
    Int J Clin Exp Pathol; 2015 Feb 26; 8(9):10800-7. PubMed ID: 26617792
    [Abstract] [Full Text] [Related]

  • 37. Overexpression of miR-301a-3p promotes colorectal cancer cell proliferation and metastasis by targeting deleted in liver cancer-1 and runt-related transcription factor 3.
    Zhang L, Zhang Y, Zhu H, Sun X, Wang X, Wu P, Xu X.
    J Cell Biochem; 2019 Apr 26; 120(4):6078-6089. PubMed ID: 30362160
    [Abstract] [Full Text] [Related]

  • 38. β-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome.
    Li J, JunYu, Liu A, Wang Y.
    Lung Cancer; 2014 Nov 26; 86(2):144-50. PubMed ID: 25204604
    [Abstract] [Full Text] [Related]

  • 39. miR-449a Suppresses LDHA-Mediated Glycolysis to Enhance the Sensitivity of Non-Small Cell Lung Cancer Cells to Ionizing Radiation.
    Li L, Liu H, Du L, Xi P, Wang Q, Li Y, Liu D.
    Oncol Res; 2018 May 07; 26(4):547-556. PubMed ID: 28800787
    [Abstract] [Full Text] [Related]

  • 40. MiR-296-3p may affect the proliferation and migration of non-small cell lung cancer cells via regulating RABL3.
    Ge T, Wu HC, Zhou YY, Shen SM, Zhu LG, You GX.
    Eur Rev Med Pharmacol Sci; 2019 Jul 07; 23(13):5823-5830. PubMed ID: 31298353
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.